List view / Grid view
3 September 2015 | By Victoria White
NICE has published final draft guidance which does not recommend apremilast, saying that there is not enough evidence to demonstrate apremilast slows progression of psoriatic arthritis...
3 September 2015 | By Victoria White
If approved, etelcalcetide will be the first calcimimetic agent that can be administered intravenously for the treatment of SHPT in patients with chronic kidney disease...
3 September 2015 | By Victoria White
Lannett Company has entered into a definitive agreement to acquire UCB’s US generics subsidiary, Kremers Urban Pharmaceuticals, for $1.23 billion...
3 September 2015 | By Victoria White
The FDA has granted Fast Track designation to iclaprim to treat acute bacterial skin and skin structure infections and hospital acquired bacterial pneumonia...
2 September 2015 | By Victoria White
Teflaro is now approved for the treatment of acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia...
2 September 2015 | By Victoria White
ABSORB Japan, a trial comparing the safety and effectiveness of Abbott's fully dissolving Absorb heart stent to Xience, has produced positive results...
2 September 2015 | By Victoria White
Positive results from RECAPTURE 1 and 2, Phase III studies evaluating the antibiotic Avycaz as a treatment for patients with cUTI, have been announced...
2 September 2015 | By Victoria White
The FDA has accepted for filing and review the supplemental Biological licence Application for Opdivo for the treatment of patients with non-squamous NSCLC...
2 September 2015 | By Coulter Partners
Global Life Sciences search specialist, Coulter Partners is pleased to announce the appointments of Nicolaj Moerk Thomsen as Senior Consultant and Lisbeth Holm as Research Associate in their new Copenhagen offices...
2 September 2015 | By Victoria White
Allergan has completed the acquisition of Naurex, a biopharmaceutical company developing therapies for challenging disorders of the central nervous system...
2 September 2015 | By Victoria White
Heart failure treatment LCZ696 (sacubitril valsartan) has been given a positive scientific opinion under the MHRA Early Access to Medicines Scheme...
2 September 2015 | By Victoria White
NICE has provisionally recommended BioMarin’s Vimizim for the treatment of the very rare inherited lysosomal storage disease, mucopolysaccharidosis type IVa...
2 September 2015 | By Victoria White
As well as granting exclusive rights to acquire Promedior, the agreement grants Bristol-Myers Squibb worldwide rights to Promedior's lead asset PRM-151.
2 September 2015 | By Victoria White
The FDA has accepted for priority review the BLA for Empliciti (elotuzumab) for the treatment of multiple myeloma as combination therapy...
2 September 2015 | By Victoria White
New TECOS study findings have shown that patients with type-2 diabetes can safely take sitagliptin without an increased risk of cardiovascular complications...
